pCDH-EF1a-hDNAJC6-T2A-copGFP
(Plasmid
#170443)
-
PurposeLentiviral vector expressing human DNAJC6 with copGFP reporter gene, under control of EF1alpha promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 170443 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCDH-EF1a-T2A-copGFP
-
Backbone manufacturerSystem Biosciences
- Backbone size w/o insert (bp) 7430
- Total vector size (bp) 10340
-
Vector typeLentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namehuman DNAJC6
-
Alt nameAuxilin
-
Alt nameDnaJ Heat Shock Protein Family (Hsp40) Member C6
-
Alt namePARK19
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2910
-
GenBank IDBC109279.2
-
Entrez GeneDNAJC6 (a.k.a. DJC6, PARK19)
- Promoter EF1a
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer GGATCTCGACGGTATCGG (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCDH-EF1a-hDNAJC6-T2A-copGFP was a gift from Sang-Hun Lee (Addgene plasmid # 170443 ; http://n2t.net/addgene:170443 ; RRID:Addgene_170443) -
For your References section:
Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked DNAJC6 mutations. Wulansari N, Darsono WHW, Woo HJ, Chang MY, Kim J, Bae EJ, Sun W, Lee JH, Cho IJ, Shin H, Lee SJ, Lee SH. Sci Adv. 2021 Feb 17;7(8). pii: 7/8/eabb1540. doi: 10.1126/sciadv.abb1540. Print 2021 Feb. 10.1126/sciadv.abb1540 PubMed 33597231